FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31811000001105: Betaloc 50mg tablets (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16292301000001112 Betaloc 50mg tablets (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54089301000001110 Betaloc 50mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betaloc 50mg tablets (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Is a Product containing precisely metoprolol tartrate 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has excipient Lactose false Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has active ingredient Metoprolol tartrate false Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Is a Betaloc true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has specific active ingredient Metoprolol tartrate true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betaloc 50mg tablets (AstraZeneca) 100 tablet 10 x 10 tablets Is pack of False Betaloc 50mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Betaloc 50mg tablets (AstraZeneca) 100 tablet 10 x 10 tablets Has AMP True Betaloc 50mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start